News

FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.

As President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.

As legislative discussions begin regarding the reauthorization of CHIP, it is imperative to keep in mind how proposed cuts could be detrimental to the health and future of our nation’s children.

A National Business Group on Health survey finds that with costs continuing to rise, employers are shifting control efforts to how healthcare is delivered and paid for.

A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.

Consumer and provider expectations have changed as a result of the digital economy. Here are four reasons why payers need to start migrating their businesses in that direction.

Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.

FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.

Managed Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal

As the opioid epidemic rages, up-and-coming physicians are seen as part of the solution. Here’s how medical schools are changing their training programs.

Do you have what it takes to succeed as a healthcare executive? Industry leaders weigh in.

How Phoenix Children’s improved access, value and outcomes through a dedicated focus on advanced practice providers.

As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.

The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.

Analytics is an integral component of healthcare no matter what Congress decides, according to one expert. Here are 4 areas of data analytics that health plans can develop that will promote future cost savings.

Here’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.

FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.

New medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.

With so much going on in health IT, it can be difficult to keep track of all the buzzwords. Here’s your quick and easy guide.

The next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.

An eye-opening study by Precision for Value assesses cancer value frameworks.

Here are three ways HealthPartners’ health plan and care delivery system work together to save customers time and money and improve their experience.

Here’s a look at four changes in the second round of healthcare bill revisions that just weren’t enough to muster up enough votes.

The medication’s ability to reduce inflammation sited as one possible explanation.

Depression is one of the most common diagnosed disorders but providers still have trouble diagnosing and treating these patients.

Study highlights the need for services and research for this understudied population.

An initiative that aims to expand the use of population health strategies has received funding to be used in 500 U.S. cities.